An Open Label Study of the Effects of Eculizumab in CD59 Deficiency
Clinical trial NCT01579838 · UNKNOWN
Trial details
- NCT number
- NCT01579838
- Sponsor
- Hadassah Medical Organization
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.